Peerbridge Health has announced the successful completion and findings of its prospective, feasibility clinical trial, resulting in a statistically significant 91.2% predictive accuracy for the determination of apnea-hypopnea index (AHI) for diagnosing obstructive sleep apnea (OSA) while using the Peerbridge Cor, a patented 3-lead, 2-channel wireless continuous ECG wearable device that allows physicians the ability to address and assess sleep and heart health remotely.
/PRNewswire/ Peerbridge Health is collaborating with Northwell Health on their newly launched AFib Center of Excellence, a mutli-displinary effort that.